New chemo delivery method shows promise for tough mesothelioma
NCT ID NCT02611037
First seen Nov 01, 2025 · Last updated Jun 01, 2026 · Updated 32 times
Summary
This study tested a way to deliver three chemotherapy drugs directly to the tumor through an artery in adults with malignant pleural mesothelioma that cannot be removed by surgery. The goal was to see if this approach is safe and can control the disease. 34 people took part in this phase 2 trial.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALIGNANT PLEURAL MESOTHELIOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
H. Lee Moffitt Cancer Center and Research Institute
Tampa, Florida, 22612, United States
Conditions
Explore the condition pages connected to this study.